The UK generic drug industry is not ready to comply with new post-Brexit labelling rules for medicines entering Northern Ireland, the manufacturers’ trade body has warned, raising the risk of supply shortages.
The British Generic Manufacturers Association said the industry had insufficient time to meet incoming requirements for medicine packs to be labelled “UK only” from January 1 2025, and urged the UK government to delay implementation of the policy.
Guidance on the labelling scheme…
Read the full article here